Recombinant Zebrafish AKT3A
Cat.No. : | AKT3A-7822Z |
Product Overview : | Recombinant Zebrafish AKT3A full length or partial length protein was expressed. |
- Specification
- Gene Information
- Related Products
Source : | Mammalian Cells |
Species : | Zebrafish |
Tag : | His |
Form : | Liquid or lyophilized powder |
Endotoxin : | < 1.0 eu per μg of the protein as determined by the LAL method. |
Purity : | >80% |
Notes : | This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications. |
Storage : | Store it at +4 oC for short term. For long term storage, store it at -20 oC~-80 oC. |
Storage Buffer : | PBS buffer |
Gene Name : | akt3a v-akt murine thymoma viral oncogene homolog 3a [ Danio rerio (zebrafish) ] |
Official Symbol : | AKT3A |
Gene ID : | 560549 |
mRNA Refseq : | NM_001197201 |
Protein Refseq : | NP_001184130 |
UniProt ID : | D9IL79 |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (8)
Ask a questionSince AKT3A is a specific isoform of AKT3, any inhibitors or modulators targeting AKT3 are likely to affect AKT3A as well. Several AKT inhibitors that broadly target AKT isoforms, including AKT3, have been developed and tested in preclinical and clinical studies. These inhibitors can potentially modulate AKT3A-mediated signaling pathways.
The specific substrates phosphorylated by AKT3A protein have not been well-elucidated. AKT3 isoforms, in general, can phosphorylate a wide range of substrates involved in cellular processes such as apoptosis, metabolism, cell cycle regulation, and cell survival. Some well-known substrates of AKT isoforms include FOXO transcription factors, mTOR, GSK-3, and Bad. It is plausible that AKT3A may phosphorylate similar substrates, but further research is needed to identify and characterize the specific substrates targeted by AKT3A.
The expression pattern of AKT3A protein in different tissues has not been extensively studied, and specific data on its expression levels and distribution are limited. However, AKT3 isoforms, including AKT3A, are generally expressed in various tissues and cell types. It is likely that the expression of AKT3A may be influenced by specific cellular contexts and conditions. Further research is needed to determine the tissue-specific expression patterns of AKT3A protein.
The involvement of AKT3A protein in disease associations has not been extensively studied or reported in the available literature. However, dysregulation of AKT signaling has been implicated in various diseases, including cancer, neurodegenerative disorders, and metabolic disorders. Changes in AKT3 activity or expression levels have been observed in certain types of cancer, such as breast and ovarian cancer. Additionally, mutations in the AKT3 gene have been associated with a rare developmental disorder called microcephaly with pontine cerebellar hypoplasia. It is possible that AKT3A may have disease associations similar to other AKT isoforms, but further research is needed to determine its specific role in disease pathways.
The specific associations between AKT3A protein and diseases have not been extensively studied or reported in the literature. However, given that aberrant AKT signaling is implicated in various diseases, including cancer, neurological disorders, and metabolic disorders, it is possible that alterations or dysregulation of AKT3A isoform could contribute to the development or progression of certain diseases. Additional research is required to determine if AKT3A has any disease-specific roles or associations.
The specific interaction partners of AKT3A protein have not been extensively studied or reported in the available literature. However, AKT isoforms, including AKT3, are known to interact with a wide range of proteins involved in various cellular processes. Some well-established interacting partners of AKT isoforms include growth factor receptors, phosphatidylinositol 3-kinase (PI3K), mammalian target of rapamycin (mTOR), and glycogen synthase kinase-3 (GSK-3). It is possible that AKT3A may have similar interaction partners, but further research is needed to determine the specific protein-protein interactions involving AKT3A.
AKT3A is a specific variant of the AKT3 protein that may have distinct functional properties compared to other isoforms. The exact differences between AKT3A and other AKT3 isoforms are not well-defined in the scientific literature. It is possible that AKT3A may have unique expression patterns, regulatory mechanisms, or interactions with specific proteins, which could influence its role in cellular signaling pathways.
The regulation of AKT3A protein is not well-characterized, and specific studies on AKT3A regulation are limited. However, AKT proteins, in general, are regulated through phosphorylation and dephosphorylation events by various upstream kinases and phosphatases. Stimuli such as growth factors, hormones, and cellular stress can activate these signaling pathways to affect AKT activation and subsequent downstream signaling. Additional research is required to better understand the regulation of AKT3A isoform specifically.
Customer Reviews (3)
Write a reviewWith the AKT3A protein in my arsenal, I am inspired to undertake my scientific investigations with great enthusiasm and confidence.
I know that any potential challenges or hurdles I may encounter will be swiftly addressed, thanks to the manufacturer's reliable and efficient technical support team.
Its high quality and the manufacturer's remarkable technical support combine to ensure that my research endeavors are executed with optimal efficiency and accuracy.
Ask a Question for All AKT3A Products
Required fields are marked with *
My Review for All AKT3A Products
Required fields are marked with *
Inquiry Basket